Concord Biotech Ltd vs Divis Laboratories Ltd
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Concord Biotech Ltd currently has the stronger revenue growth signal.
Concord Biotech Ltd and Divis Laboratories Ltd show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Concord Biotech Ltd | Divis Laboratories Ltd |
|---|---|---|
| Current Price | ₹1,494 | ₹9,375 |
| Market Cap | ₹15,752.06 Cr. | ₹2.47 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 55.4 | 83.06 |
| ROE (%) | 12.57 | 16.53 |
| Debt/Equity | — | — |
| Sales Growth 5Y (%) | 11.33 | 8.67 |
| Profit Growth 5Y (%) | 33.34 | 53.16 |
| Promoter Holding (%) | 44.08 | 51.88 |
| Revenue Rank | Rank 2 | Rank 3 |
| Margin Rank | Rank 1 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |